These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9108818)

  • 21. A case report of megaloblastic anemia secondary to lithium.
    Prakash R; Sethi N; Agrawal SS; Kushwaha MR; Sethi BB
    Am J Psychiatry; 1981 Jun; 138(6):849. PubMed ID: 7246823
    [No Abstract]   [Full Text] [Related]  

  • 22. Valproate-induced hyperammonemia in the psychiatric setting: 2 cases.
    Panikkar GP; Gilman SM
    J Clin Psychiatry; 1999 Aug; 60(8):557-9. PubMed ID: 10485644
    [No Abstract]   [Full Text] [Related]  

  • 23. A case of hyperammonemic encephalopathy after 11 years of valproate therapy.
    Stewart JT
    J Clin Psychopharmacol; 2008 Jun; 28(3):361-2. PubMed ID: 18480705
    [No Abstract]   [Full Text] [Related]  

  • 24. Unexpected interaction between quetiapine and valproate in patients with bipolar disorder.
    Huang CC; Wei IH
    Gen Hosp Psychiatry; 2010; 32(4):446.e1-2. PubMed ID: 20633751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid development of severe skin rash after adding valproic acid in a case of bipolar depression treated with low-dose lamotrigine.
    Chou YC; Chao FH; Chou YH
    J Formos Med Assoc; 2014 Mar; 113(3):195-6. PubMed ID: 24630038
    [No Abstract]   [Full Text] [Related]  

  • 26. Blood dyscrasia with quetiapine and ziprasidone.
    Nair P; Lippmann S
    Psychosomatics; 2005; 46(1):89-90. PubMed ID: 15765830
    [No Abstract]   [Full Text] [Related]  

  • 27. Lifetime treatment of mice with azidothymidine (AZT) produces myelodysplasia.
    Inoue T; Cronkite EP; Hirabayashi Y; Bullis JE; Mitsui H; Umemura T
    Leukemia; 1997 Apr; 11 Suppl 3():123-7. PubMed ID: 9209318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
    Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
    Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valproate-induced reversible pseudoatrophy of the brain and hyperammonemic encephalopathy in a bipolar patient.
    Abreu LN; Issler C; Lafer B
    Aust N Z J Psychiatry; 2009 May; 43(5):484-5. PubMed ID: 19382315
    [No Abstract]   [Full Text] [Related]  

  • 30. A clinically significant interaction between carbamazepine and valproic acid.
    Sovner R
    J Clin Psychopharmacol; 1988 Dec; 8(6):448-9. PubMed ID: 3148642
    [No Abstract]   [Full Text] [Related]  

  • 31. Thrombocytopenia associated with sodium valproate treatment.
    Neophytides AN; Nutt JG; Lodish JR
    Ann Neurol; 1979 Apr; 5(4):389-90. PubMed ID: 375808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Valproate for bipolar disorder.
    Med Lett Drugs Ther; 1994 Aug; 36(929):74-5. PubMed ID: 8047048
    [No Abstract]   [Full Text] [Related]  

  • 33. Combining lithium and sodium valproate for bipolar disorder.
    Mitchell P; Withers K; Jacobs G; Hickie I
    Aust N Z J Psychiatry; 1994 Mar; 28(1):141-3. PubMed ID: 8067959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Valproate-associated dysmyelopoiesis in elderly patients.
    So CC; Wong KF
    Am J Clin Pathol; 2002 Aug; 118(2):225-8. PubMed ID: 12162682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sodium valproate and thrombocytopenia.
    Hoffman LM
    Can Med Assoc J; 1982 Feb; 126(4):358-9. PubMed ID: 6802479
    [No Abstract]   [Full Text] [Related]  

  • 36. Fulminant hepatic failure in the context of reinstituting valproate use.
    Rej S; Chen T; Edwards M; Zicherman V
    Psychosomatics; 2014; 55(3):303-4. PubMed ID: 24360531
    [No Abstract]   [Full Text] [Related]  

  • 37. Valproate-associated reproductive hormone abnormalities: do bipolar men have the same risk as epileptic men?
    Aldemir E; Akdeniz F; Altay AB; Arıcı Ş; Umul M; Aydın HH; Çelebisoy M; Vahip S
    Turk Psikiyatri Derg; 2012; 23(4):223-7. PubMed ID: 23225122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic drug-drug interactions between olanzapine and valproate need to be better studied.
    de Leon J; Diaz FJ; Spina E
    J Clin Psychiatry; 2010 Jul; 71(7):957-8; author reply 958-9. PubMed ID: 20667295
    [No Abstract]   [Full Text] [Related]  

  • 39. Bipolar disorder and valproate-induced hyperammonemic encephalopathy in an adolescent with diabetes.
    Young L; Coffey BJ
    J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):449-52. PubMed ID: 20973717
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug interaction between carbapenems and extended-release divalproex sodium in a patient with schizoaffective disorder.
    Muzyk AJ; Candeloro CL; Christopher EJ
    Gen Hosp Psychiatry; 2010; 32(5):560.e1-3. PubMed ID: 20851283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.